AETIONOMY Archives – Page 3 of 3

Neuronet Scientific Coordination Board meeting brings together project leaders

3rd December 20217th July 2019

Scientific Coordination Board, Carlos Diaz, Hugh Marston, George Tofaris, Mercè Boada, Pieter Jelle Visser, Darrel Pemberton, Craig Ritchie, Andreas Ebneth, Malcolm Macleod, Margot Bakker

Neuronet’s high-level, overarching Scientific Coordination Board is formed by 15 leaders of Innovative Medicines Initiative projects focussed on neurodegeneration.

How the digital revolution is transforming EU-funded brain research

4th February 20204th June 2019

Two Innovative Medicines Initiative neurodegeneration projects are featured in the CORDIS brochure on how the

AETIONOMY final symposium and IMI neurodegeneration initiatives

4th February 202030th November 2018

In December 2018, the AETIONOMY project reached the end of its funded period. The challenge

LATEST NEWS

Watch interviews with RADAR-CNS researchers and members of its Patient Advisory Board
8th August 2022
RADAR-CNS was a Innovative Medicines Initiative (IMI) funded collaborative research project that explored the potentialRead More
Spotlight on Communication experts: A Neuronet Blog with Yoanna de Geus
1st August 2022
Neuronet is a Coordination and Support Action for the Innovative Medicines Initiative’s research projects onRead More
AMYPAD announces Last Patient Out in its Prognostic Study
15th July 2022
On the 30 June, the members of the Amyloid Imaging to Prevent Alzheimer’s Disease (AMYPAD)Read More
AAIC workshop on fluid biomarkers features EPND partners, Charlotte Teunissen and Henrik Zetterberg
8th July 2022
The Alzheimer’s Association International Conference (AAIC), organised annually by the US Alzheimer’s Association, is knownRead More
PD-MitoQUANT holds Final Project Meeting in Copenhagen
7th July 2022
Time has certainly flown! With the PD-MitoQUANT project formally ending in July 2022, project partnersRead More